Table 3.
Outcome | SES-D | GAD-2 | FAD | CESD-8 | N | R2 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | Std. B | FDR q | B | Std. B | FDR q | B | Std. B | FDR q | B | Std. B | FDR q | |||
TNF-α pg/mL | 0.13a | 0.28 | 0.011 | 0.01 | 0.14 | 0.362 | −0.01 | 0.00 | 0.657 | 0.00 | −0.28 | 0.407 | 71 | 0.10 |
IL-1β pg/mL | 0.10a | 0.19 | 0.033 | −0.02 | −0.05 | 0.362 | 0.00 | −0.02 | 0.863 | 0.00 | −0.04 | 0.407 | 142 | 0.04 |
IL-6 pg/mL | 0.03 | 0.06 | 0.524 | 0.02 | 0.06 | 0.362 | −0.02 | −0.10 | 0.303 | 0.01 | 0.06 | 0.407 | 138 | 0.02 |
IL-8 pg/mL | 0.07 | 0.14 | 0.122 | −0.01 | −0.02 | 0.438 | −0.01 | −0.04 | 0.702 | 0.01 | 0.05 | 0.407 | 139 | 0.02 |
Cortisol pg/mg | −0.02 | −0.02 | 0.871 | −0.08 | −0.15 | 0.362 | 0.08a | 0.27 | 0.033 | 0.03 | 0.13 | 0.407 | 79 | 0.09 |
Cortisone pg/mg | 0.00 | 0.00 | 0.995 | 0.02 | 0.08 | 0.362 | 0.05a | 0.37 | 0.003 | −0.02 | −0.21 | 0.319 | 79 | 0.10 |
DHEA pg/mg | 0.16a | 0.35 | 0.011 | 0.03 | 0.14 | 0.362 | 0.00 | 0.00 | 0.982 | −0.03 | −0.28 | 0.294 | 76 | 0.09 |
Note: bold values indicate FDR-adjusted significant associations (q < 0.05).
SES-D socioeconomic disadvantage index, CESD-8 Center for Epidemiological Depression scale, GAD-2 Generalized Anxiety Disorder scale, FAD Family Assessment Device, Std. standardized.
aSignificant at 5% bootstrap levels.